Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Tuesday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE AMPE opened at $0.00 on Tuesday. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $7.47. The stock has a market capitalization of $2,951.00, a PE ratio of 0.00 and a beta of 2.21. The business’s 50-day moving average is $0.06 and its 200 day moving average is $0.59.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.